Individualisierte Therapie beim Pankreaskarzinom

Marcus Bahra, Ulf Neumann, Surgical Techniques for Resectable Pancreatic Cancer Pancreatic Cancer. ,vol. 177, pp. 29- 38 ,(2008) , 10.1007/978-3-540-71279-4_4

Irfan Cicin, Sernaz Uzunoglu, Ozgur Tanriverdi, Esma Turkmen, Bulent Erdogan, Performance status is an important prognostic factor in second line treatment of pancreaticobiliary adenocarcinoma. Hepato-gastroenterology. ,vol. 60, pp. 1479- 1483 ,(2013) , 10.5754/HGE13269

Mukesh Kumar, Vinicius Ernani, Taofeek K. Owonikoko, Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer. Molecular Aspects of Medicine. ,vol. 45, pp. 55- 66 ,(2015) , 10.1016/J.MAM.2015.06.009

Clifford J. Whatcott, Haiyong Han, Daniel D. Von Hoff, Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer The Cancer Journal. ,vol. 21, pp. 299- 306 ,(2015) , 10.1097/PPO.0000000000000140

Raphaël Marechal, Jean-Luc Van Laethem, Towards a tailored therapy in pancreatic cancer. Acta Gastro-enterologica Belgica. ,vol. 76, pp. 49- 56 ,(2013)

Ralph H. Hruban, Scott E. Kern, Michael Goggins, Jennifer Parsons, Progression Model for Pancreatic Cancer Clinical Cancer Research. ,vol. 6, pp. 2969- 2972 ,(2000)

Gilda da Cunha Santos, Neesha Dhani, Dongsheng Tu, Kayu Chin, Olga Ludkovski, Suzanne Kamel‐Reid, Jeremy Squire, Wendy Parulekar, Malcolm J Moore, Ming Sound Tsao, None, Molecular Predictors of Outcome in a Phase 3 Study of Gemcitabine and Erlotinib Therapy in Patients With Advanced Pancreatic Cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3 Cancer. ,vol. 116, pp. 5599- 5607 ,(2010) , 10.1002/CNCR.25393

Milena Gusella, Felice Pasini, Caterina Bolzonella, Silvia Meneghetti, Carmen Barile, Antonio Bononi, Silvia Toso, Daniela Menon, Giorgio Crepaldi, Yasmina Modena, Laura Stievano, Roberto Padrini, Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. British Journal of Clinical Pharmacology. ,vol. 71, pp. 437- 444 ,(2011) , 10.1111/J.1365-2125.2010.03838.X

M. Sinn, H. Riess, B.V. Sinn, J.M. Stieler, U. Pelzer, J.K. Striefler, H. Oettle, M. Bahra, C. Denkert, H. Bläker, P. Lohneis, Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial European Journal of Cancer. ,vol. 51, pp. 1546- 1554 ,(2015) , 10.1016/J.EJCA.2015.05.005

Filippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, Maria Di Bartolomeo, Fotios Loupakis, Claudia Maggi, Carlotta Antoniotti, Filippo de Braud, Alfredo Falcone, Roberto Iacovelli, First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis. Critical Reviews in Oncology Hematology. ,vol. 96, pp. 156- 166 ,(2015) , 10.1016/J.CRITREVONC.2015.05.016